Medical devices, healthcare technology and the business of care
PMA approval · P060022

AKREOS POSTERIOR CHAMBER INTRAOCULAR LENS,MODEL ADAPT

Bausch + Lomb, Inc. · Decision date Sep 5, 2008

MEDTECHLEDGER EXPLANATIONP060022

What did the FDA approve?

FDA approved PMA P060022 on September 5, 2008, for the Akreos Posterior Chamber Intraocular Lens, Model Adapt, specifically the Akreos Advanced Optics Aspheric Lens, AO60. The approval covers primary implantation for visual correction of aphakia in adults after cataract removal by phacoemulsification, with placement in the capsular bag.

The source statement does not identify a supplement type or reason, so no relationship to a prior PMA scope change is established. The statement reports the device's intended purpose but does not provide independent evidence of safety or clinical effectiveness.

FDA approval order statement

APPROVAL FOR THE AKREOS POSTERIOR CHAMBER INTRAOCULAR LENS (IOL), MODEL: AKREOS ADVANCED OPTICS ASPHERIC LENS, AO60. THE DEVICE IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS WHERE A CATARACTOUS LENS HAS BEEN REMOVED BY PHACOEMULSIFI-CATION. THE LENS IS INTENDED TO BE PLACED IN THE CAPSULAR BAG.
Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
Sep 5, 2008

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060022
Regulatory pathway
Premarket approval application
Product code
HQL
Decision code
APPR
Decision date
Sep 5, 2008
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P060022 received

    Application receipt date recorded by FDA.

  2. P060022 · FDA decision

    APPR

  3. P060022/S038 · Related supplement

    Akreos posterior chamber intraocular lens

Timeline entries are records held by MedtechLedger for P060022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060022

Product / regulatory recordCompanyPathwayDecision dateSource
Bausch + Lomb, Inc.PMA supplementSep 3, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
50 Technology Dr., Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records